Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Romy E. van Weelderen"'
Autor:
Romy E. Van Weelderen, Kim Klein, Bianca F. Goemans, Wim J. E. Tissing, Tom F. W. Wolfs, Gertjan J. L. Kaspers
Publikováno v:
Cancers, Vol 14, Iss 13, p 3172 (2022)
Bloodstream infections (BSIs), especially those caused by Gram-negative rods (GNR) and viridans group streptococci (VGS), are common and potentially life-threatening complications of pediatric acute myeloid leukemia (AML) treatment. Limited literatur
Externí odkaz:
https://doaj.org/article/6c6d9f1d9790481ab3b80b1ad151a353
Autor:
Romy E. van Weelderen, Kim Klein, Christine J. Harrison, Yilin Jiang, Jonas Abrahamsson, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Riccardo Masetti, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan, Gertjan J.L. Kaspers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(16), 2963-2974. American Society of Clinical Oncology
van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120
JOURNAL OF CLINICAL ONCOLOGY
van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120
JOURNAL OF CLINICAL ONCOLOGY
PURPOSE A previous study by the International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) on childhood KMT2A-rearranged ( KMT2A-r) AML demonstrated the prognostic value of the fusion partner. This I-BFM-SG study investigated the value of flow cy
Autor:
Festus Njuguna, Gilbert Olbara, Saskia Mostert, Kim Klein, Romy E. Van Weelderen, Sandra Langat, Gertjan J.L. Kaspers, Martha Kipng'etich, Terry A. Vik
Publikováno v:
van Weelderen, R E, Njuguna, F, Klein, K, Mostert, S, Langat, S, Vik, T A, Olbara, G, Kipng'etich, M & Kaspers, G J L 2022, ' Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya ', Cancer reports (Hoboken, N.J.), vol. 5, no. 10, e1576 . https://doi.org/10.1002/cnr2.1576
Cancer reports (Hoboken, N.J.), 5(10):e1576. Wiley-Blackwell Publishing Ltd
Cancer reports (Hoboken, N.J.), 5(10):e1576. Wiley-Blackwell Publishing Ltd
Background: Pediatric acute myeloid leukemia (AML) is a challenging disease to treat in low- and middle-income countries (LMICs). Literature suggests that survival in LMICs is poorer compared with survival in high-income countries (HICs). Aims: This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c73689067f346cf07214c2a0ee48e16
https://research.vumc.nl/en/publications/6f2d2203-7c0f-4245-bcc1-c03ef6e80c83
https://research.vumc.nl/en/publications/6f2d2203-7c0f-4245-bcc1-c03ef6e80c83
Autor:
Ralph de Vries, Gertjan J.L. Kaspers, Romy E. Van Weelderen, Kim Klein, Meyrina D Natawidjaja
Publikováno v:
Expert Review of Anticancer Therapy, 21(7), 765-780. Taylor and Francis Ltd.
van Weelderen, R E, Klein, K, Natawidjaja, M D, de Vries, R & Kaspers, G J L 2021, ' Outcome of pediatric acute myeloid leukemia (AML) in low-and middle-income countries : a systematic review of the literature ', Expert Review of Anticancer Therapy, vol. 21, no. 7, pp. 765-780 . https://doi.org/10.1080/14737140.2021.1895756
van Weelderen, R E, Klein, K, Natawidjaja, M D, de Vries, R & Kaspers, G J L 2021, ' Outcome of pediatric acute myeloid leukemia (AML) in low-and middle-income countries : a systematic review of the literature ', Expert Review of Anticancer Therapy, vol. 21, no. 7, pp. 765-780 . https://doi.org/10.1080/14737140.2021.1895756
Introduction: Survival rates of pediatric acute myeloid leukemia (AML) in low- and middle-income countries (LMICs) seem extremely poor, and the available literature on the matter is scarce. Accordingly, there is a limited understanding of poor treatm
Autor:
Christine von Neuhoff, Dirk Reinhardt, Yves Bertrand, Kim Klein, Sarah Elitzur, Jonas Abrahamsson, Guy Leverger, Jacqueline Cloos, Ursula Creutzig, Valerie de Haas, Romy E. Van Weelderen, Pter Smisek, Martin Zimmermann, Henrik Hasle, Brenda Gibson, Alcira Fynn, Bassem I. Razzouk, Alexei Maschan, Shau Yin Ha, Michael Dworzak, Christine J. Harrison, H. Berna Beverloo, Carmelo Rizzari, Gertjan J.L. Kaspers, Susana C. Raimondi
Publikováno v:
Pediatric Blood and Cancer, 69(1):e29341. Wiley-Liss Inc.
Klein, K, Beverloo, H B, Zimmermann, M, Raimondi, S C, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S Y, Harrison, C J, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U & Kaspers, G J L 2022, ' Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study ', Pediatric Blood and Cancer, vol. 69, no. 1, e29341 . https://doi.org/10.1002/pbc.29341
Klein, K, Beverloo, H B, Zimmermann, M, Raimondi, S C, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S-Y, Harrison, C J, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U & Kaspers, G J L 2022, ' Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study ', Pediatric Blood & Cancer, vol. 69, no. 1, e29341 . https://doi.org/10.1002/pbc.29341
Klein, K, Beverloo, H B, Zimmermann, M, Raimondi, S C, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S Y, Harrison, C J, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U & Kaspers, G J L 2022, ' Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study ', Pediatric Blood and Cancer, vol. 69, no. 1, e29341 . https://doi.org/10.1002/pbc.29341
Klein, K, Beverloo, H B, Zimmermann, M, Raimondi, S C, von Neuhoff, C, de Haas, V, van Weelderen, R, Cloos, J, Abrahamsson, J, Bertrand, Y, Dworzak, M, Fynn, A, Gibson, B, Ha, S-Y, Harrison, C J, Hasle, H, Elitzur, S, Leverger, G, Maschan, A, Razzouk, B, Reinhardt, D, Rizzari, C, Smisek, P, Creutzig, U & Kaspers, G J L 2022, ' Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 Study ', Pediatric Blood & Cancer, vol. 69, no. 1, e29341 . https://doi.org/10.1002/pbc.29341
BACKGROUND: In addition to treatment response, cytogenetic and molecular aberrations are the most important prognostic factors in children with de novo acute myeloid leukemia (AML). However, little is known about cytogenetics at the time of relapse.M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803fea05029ddfdbff93d7ee929a6a32
https://www.ncbi.nlm.nih.gov/pubmed/34532968
https://www.ncbi.nlm.nih.gov/pubmed/34532968
Autor:
Jan Stary, Barbara Buldini, Henrik Hasle, Marta Fiocco, Barbara De Moerloose, Hester A. de Groot-Kruseman, Daisuke Tomizawa, Emmanuelle Bart-Delabesse, Takako Miyamura, Femke Verwer, Shau-Yin Ha, Gertjan J.L. Kaspers, Mareike Rasche, Hélène Lapillonne, Sarah Elitzur, Bianca F. Goemans, Kathy Jackson, Jeffrey E. Rubnitz, C. Michel Zwaan, Michael Dworzak, Guy Leverger, Franco Locatelli, José M. Fernández Navarro, Sophia Polychronopoulou, Jonas Abrahamsson, Romy E. Van Weelderen, Christine J. Harrison, Robert B. Gerbing, Nira Arad-Cohen, Charikleia Kelaidi, Kim Klein, Erin M. Guest
Publikováno v:
Blood. 138:2360-2360
Introduction KMT2A-rearranged (KMT2A-r) acute myeloid leukemia (AML) is a heterogeneous genetic subgroup with a frequency of about 25% in children with AML. At the 62 nd ASH annual meeting last year, we reported on the differences in outcome of vario
Autor:
Henrik Hasle, Hester A. de Groot-Kruseman, Femke Verwer, Franco Locatelli, Jeffrey E. Rubnitz, Christine J. Harrison, Bianca F. Goemans, Emmanuelle Bart-Delabesse, Jan Stary, Barbara Buldini, Daisuke Tomizawa, Michael Dworzak, Guy Leverger, Sophia Polychronopoulou, Mareike Rasche, Shau-Yin Ha, Kim Klein, Robert B. Gerbing, Nira Arad-Cohen, Kathy Jackson, Barbara De Moerloose, Erin M. Guest, Charikleia Kelaidi, Hélène Lapillonne, Takako Miyamura, José M. Fernández Navarro, Jonas Abrahamsson, Romy E. Van Weelderen, Sarah Elitzur, Gertjan J.L. Kaspers, Christian M. Zwaan
Publikováno v:
Blood. 136:26-27
Introduction Outcome of KMT2A-rearranged (KMT2A-r) pediatric AML (pAML) is in general poor with a 5-year probability of event-free survival (5y-pEFS) and overall survival (5y-pOS) of 44% and 56%, respectively (Balgobind et al., 2009). However, over t